NON-CLINICAL SAFETY OF PTH-IA, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE.

NIH RePORTER · NIH · N01 · $115,334 · view on reporter.nih.gov ↗

Abstract

The objective of this study is to determine toxicity and toxicokinetics of PTH-IA after BID daily subcutaneous administration in 7 day old rats for 6 month with a 28 days recovery period.

Key facts

NIH application ID: 11041824
Project number: 271201700016I-P00006-759502000001-1
Recipient: IIT RESEARCH INSTITUTE
Principal Investigator: THOMAS HORN
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $115,334
Award type: —
Project period: 2020-09-16 → 2024-07-08